Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 11;37(3):311-319.
doi: 10.1515/reveh-2021-0036. Print 2022 Sep 27.

Factors influencing the prevalence of polycystic ovary syndrome (PCOS) in the United Arab Emirates

Sarah Dalibalta  1 , Yara Abukhaled  1 , Fatin Samara  1
Affiliations
Review

Factors influencing the prevalence of polycystic ovary syndrome (PCOS) in the United Arab Emirates

Sarah Dalibalta et al. Rev Environ Health. .

Abstract

Statistics indicate that at least 20-25% of women suffer from PCOS in the Gulf region. Despite its prevalence and negative implications on reproductive, metabolic, and physiological heath the exact cause of PCOS is unknown, in part due to the diversity of symptoms manifested by this disorder. In this review, we investigate causes of PCOS globally and draw on these studies, to determine the potential contributing factors for PCOS pathogenesis in the UAE population. The most frequently identified factors promoting PCOS pathogenesis that may be pertinent to this population include physiological factors such as insulin resistance, vitamin D deficiency, genetic factors, obesity, and anti-mullerian hormone (AMH) levels in the body as well as environmental factors such as air pollution, endocrine disrupting chemicals, and pesticide use. This evidence will help inform healthcare workers and government agencies to set up optimal guidelines for control and awareness of PCOS in the UAE.

Keywords: PCOS; UAE; environmental factors; physiological factors; prevalence.

PubMed Disclaimer

References

    1. Melo, AS, Ferriani, RA, Navarro, PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics 2015;70:765–9. https://doi.org/10.6061/clinics/2015(11)09.
    1. Bani Mohammad, M, Majdi Seghinsara, A. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac J Cancer Prev APJCP 2017;18:17–21. https://doi.org/10.22034/APJCP.2017.18.1.17.
    1. Knochenhauer, ES, Key, TJ, Kahsar-Miller, M, Waggoner, W, Boots, LR, Azziz, R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–82. https://doi.org/10.1210/jcem.83.9.5090.
    1. Kauffman, RP, Baker, VM, DiMarino, P, Gimpel, T, Castracane, VD. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002;187:1362–9. https://doi.org/10.1067/mob.2002.126650.
    1. Naz, MS, Tehrani, FR, Majd, HA, Ahmadi, F, Ozgoli, G, Fakari, FR, et al.. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. Int J Reprod Biomed 2019;17:533–42. https://doi.org/10.18502/ijrm.v17i8.4818.

Substances

LinkOut - more resources